Cargando…

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

BACKGROUND: Hepatitis B infection, caused by hepatitis B Virus (HBV), is one of the major global public health problems. Hepatitis B Virus genotypes appear to show varying geographic distribution with possible pathogenic and therapeutic differences. Knowledge of HBV genotypes is very important for c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karimi, Ali, Salimzadeh, Loghman, Bagheri, Nader
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138629/ https://www.ncbi.nlm.nih.gov/pubmed/25147693 http://dx.doi.org/10.5812/jjm.10196

Ejemplares similares

High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B
por: Wani, Hamid Ullah, et al.
Publicado: (2014)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
por: Chen, En-Qiang, et al.
Publicado: (2009)

Lamivudine Therapy for Korean Children with Chronic Hepatitis B
por: Koh, Hong, et al.
Publicado: (2007)

Appropriate Genotyping of Hepatitis B Virus in Iran
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2015)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
por: Park, Chan Ho, et al.
Publicado: (2016)

Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B
por: Chao, Daniel C, et al.
Publicado: (2013)

Hepatitis B Genotypes in Iran
por: Haghshenas, Mohammad Reza, et al.
Publicado: (2014)

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
por: Kanda, Tatsuo, et al.
Publicado: (2011)

Entecavir and lamivudine therapy for severe acute chronic hepatitis B
por: LIU, CHANGHONG, et al.
Publicado: (2013)

Overlapping Gene Mutations of Hepatitis B Virus in a Chronic Hepatitis B Patient with Hepatitis B Surface Antigen Loss during Lamivudine Therapy
por: Lee, Sun-Young, et al.
Publicado: (2005)

Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
por: Lin, Ming-Tsung, et al.
Publicado: (2013)

Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil
por: Bottecchia, Marcelle, et al.
Publicado: (2008)

Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
por: Moon, Ju-Young, et al.
Publicado: (2012)

Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus
por: Kim, Kang Mo, et al.
Publicado: (2005)

Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B
por: Shakado, Satoshi, et al.
Publicado: (2008)

Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
por: Luo, Aoran, et al.
Publicado: (2019)

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
por: Kim, Jeong Han, et al.
Publicado: (2014)

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study
por: Rodríguez, Manuel, et al.
Publicado: (2017)

Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
por: Kim, Jihyun, et al.
Publicado: (2015)

Current Role of Lamivudine Regarding Therapeutic Response and Resistance in Children with Chronic Hepatitis B
por: Hong, Suk Jin, et al.
Publicado: (2013)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
por: Kim, Jeong Han, et al.
Publicado: (2013)

Sequence-based genotyping of hepatitis B virus in general population
por: Karimi, Ali, et al.
Publicado: (2015)

Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)

Seroclearance of Hbsag in Chronic Hepatitis B Virus Patients on Lamivudine Therapy: A 10 Year Experience
por: Sali, Shahnaz, et al.
Publicado: (2015)

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
por: Woo, Hyun Young, et al.
Publicado: (2014)

Substitution Rtq267h of Hepatitis B Virus Increases the Weight of Replication and Lamivudine Resistance
por: Qin, Bo, et al.
Publicado: (2013)

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
por: Jung, Young Kul, et al.
Publicado: (2011)

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
por: Jeon, Hee-Jeong, et al.
Publicado: (2017)

Hepatitis B virus Genotypes in West Azarbayjan Province, Northwest Iran
por: Ansari, Mohammad Hasan Khadem, et al.
Publicado: (2017)

Distribution of Hepatitis B Virus Genotypes in Azerbaijani Patients With Chronic Hepatitis B Infection
por: Bokharaei-Salim, Farah, et al.
Publicado: (2014)

Hepatitis B virus genotyping in chronic hepatitis B patients in southwestern Saudi Arabia
por: Asaad, Ahmed Morad, et al.
Publicado: (2015)

Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy
por: Huang, Meijin, et al.
Publicado: (2019)

Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
por: Wang, Zhao, et al.
Publicado: (2011)

Association of Homozygous Thrombophilia Polymorphisms and Venous Thromboembolism in Shahrekord, Iran
por: Rouhi-Broujeni, Hamid, et al.
Publicado: (2016)

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
por: Sheng, Yun-Jian, et al.
Publicado: (2011)

Evaluation of adefovir & lamivudine in chronic hepatitis B: Correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis
por: Pradeep, Kumar S, et al.
Publicado: (2011)

Evaluation of the Cost-Effectiveness of Entecavir Versus Lamivudine in Hepatitis BeAg-Positive Chronic Hepatitis B Patients
por: Yuan, Yong, et al.
Publicado: (2008)

Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients
por: Pereira-Gómez, Marianoel, et al.
Publicado: (2016)

Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Kim, Jung Hee, et al.
Publicado: (2016)

Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus
por: Liu, Hongcan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mdcb44sj2521eu3fkg94tqoe74